We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSFS icon
951
WSFS Financial
WSFS
$4.16B
$473K ﹤0.01%
9,285
+1,612
+21% +$83.5K
SCHD icon
952
Schwab US Dividend Equity ETF
SCHD
$105B
$472K ﹤0.01%
16,761
+7,395
+79% +$201K
CIBR icon
953
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.2B
$471K ﹤0.01%
+7,948
New +$454K
AEM icon
954
Agnico Eagle Mines
AEM
$73.4B
$471K ﹤0.01%
5,841
+55
+1% +$4.26K
GAP
955
The Gap Inc
GAP
$7.36B
$468K ﹤0.01%
21,238
+1,138
+6% +$25.3K
SMPL icon
956
Simply Good Foods
SMPL
$918M
$468K ﹤0.01%
13,452
+702
+6% +$23.8K
MKL icon
957
Markel Group
MKL
$25.4B
$467K ﹤0.01%
298
-46
-13% -$72K
AXON
958
Axon Enterprise
AXON
$44.3B
$463K ﹤0.01%
1,158
-171
-13% -$59K
VTR icon
959
Ventas
VTR
$47.5B
$462K ﹤0.01%
7,203
-112
-2% -$6.54K
DVYE icon
960
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
$459K ﹤0.01%
16,000
– –
DB icon
961
Deutsche Bank
DB
$69.2B
$459K ﹤0.01%
26,522
-589
-2% -$9.46K
CENTA icon
962
Central Garden & Pet Co Class A
CENTA
$2.43B
$457K ﹤0.01%
14,558
+71
+0.5% +$2.36K
CTRA
963
DELISTED
Coterra Energy
CTRA
$456K ﹤0.01%
19,045
+1,719
+10% +$42.4K
VFVA icon
964
Vanguard US Value Factor ETF
VFVA
$913M
$455K ﹤0.01%
3,778
– –
NAMS icon
965
NewAmsterdam Pharma
NAMS
$3.28B
$455K ﹤0.01%
27,420
+290
+1% +$5.02K
CSL icon
966
Carlisle Companies
CSL
$13.3B
$451K ﹤0.01%
1,003
+105
+12% +$43.4K
CLH icon
967
Clean Harbors
CLH
$17.5B
$450K ﹤0.01%
1,862
-737
-28% -$173K
BAC.PRL icon
968
Bank of America Series L
BAC.PRL
$3.95B
$446K ﹤0.01%
350
– –
MHK icon
969
Mohawk Industries
MHK
$7.01B
$445K ﹤0.01%
2,768
-858
-24% -$123K
MSA icon
970
Mine Safety
MSA
$6.84B
$444K ﹤0.01%
2,504
+885
+55% +$161K
MWA icon
971
Mueller Water Products
MWA
$3.94B
$444K ﹤0.01%
20,443
-1,678
-8% -$33.8K
L icon
972
Loews
L
$24.6B
$443K ﹤0.01%
5,605
+952
+20% +$74.7K
NDSN icon
973
Nordson
NDSN
$16.6B
$443K ﹤0.01%
1,687
+26
+2% +$6.36K
IWX icon
974
iShares Russell Top 200 Value ETF
IWX
$3.97B
$442K ﹤0.01%
5,441
– –
WK icon
975
Workiva
WK
$3.46B
$441K ﹤0.01%
5,568
-59
-1% -$4.43K
37 38
39
40 41

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.